Time to deterioration of symptoms with durvalumab in stage III, locally advanced, unresectable NSCLC: Post-hoc analysis of PACIFIC patient-reported outcomes

Simple item page
dc.contributor.authorHui, R.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorVillegas, A.
dc.contributor.authorDaniel, D.
dc.contributor.authorVicente, D.
dc.contributor.authorMurakami, S.
dc.contributor.authorRyden, A.
dc.contributor.authorZhang, Y.
dc.contributor.authorDennis, P.
dc.contributor.authorAntonia, S.
dc.contributor.authoraffiliation[Hui, R.] Westmead Hosp, Sydney, NSW, Australia
dc.contributor.authoraffiliation[Ozguroglu, M.] Istanbul Univ, Cerrahpasa Fac Med, Div Med Oncol, Istanbul, Turkey
dc.contributor.authoraffiliation[Villegas, A.] Florida Canc Specialists, Tampa, FL USA
dc.contributor.authoraffiliation[Daniel, D.] Tennessee Oncol, Chattanooga, TN USA
dc.contributor.authoraffiliation[Vicente, D.] Hosp Univ Virgen Macarena, Seville, Spain
dc.contributor.authoraffiliation[Murakami, S.] Natl Canc Ctr, Res Inst, Thorac Oncol, Tokyo, Japan
dc.contributor.authoraffiliation[Ryden, A.] AstraZeneca, Gaithersburg, MD USA
dc.contributor.authoraffiliation[Zhang, Y.] AstraZeneca, Gaithersburg, MD USA
dc.contributor.authoraffiliation[Dennis, P.] AstraZeneca, Gaithersburg, MD USA
dc.contributor.authoraffiliation[Antonia, S.] Univ S Florida, H Lee Moffitt Canc Ctr, Thorac Oncol, Tampa, FL USA
dc.contributor.funderAstraZeneca
dc.date.accessioned2025-01-07T16:01:33Z
dc.date.available2025-01-07T16:01:33Z
dc.date.issued2018-04-01
dc.identifier.doi10.1016/S1556-0864(18)30401-5
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S1556086418304015/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27571
dc.identifier.wosID436557600122
dc.issue.number4
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS71-S71
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.titleTime to deterioration of symptoms with durvalumab in stage III, locally advanced, unresectable NSCLC: Post-hoc analysis of PACIFIC patient-reported outcomes
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number13
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen del Rocío
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía